Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
Editorial Group: Cochrane Colorectal Cancer Group
Published Online: 28 FEB 2013
Assessed as up-to-date: 16 JUL 2012
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
De Caluwé L, Van Nieuwenhove Y, Ceelen WP. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD006041. DOI: 10.1002/14651858.CD006041.pub3.
- Publication Status: New search for studies and content updated (no change to conclusions)
- Published Online: 28 FEB 2013
This article has been cited by:
- 1Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review, European Journal of Clinical Pharmacology, 2015, 71, 5, 529, , , , ,
- 2GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer, Cancer Research and Treatment, 2015, 47, 4, 804, , , , , , , ,
- 3Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature, Langenbeck's Archives of Surgery, 2015, 400, 6, 661, , ,
- 4Functional Consequences of Colorectal Cancer Management, Surgical Oncology Clinics of North America, 2014, 23, 1, 127, ,
- 5Intraoperative Radiation Therapy Reduces Local Recurrence Rates in Patients With Microscopically Involved Circumferential Resection Margins After Resection of Locally Advanced Rectal Cancer, International Journal of Radiation Oncology*Biology*Physics, 2014, 88, 5, 1032, , , , , , ,
- 6Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathway, Cancer Letters, 2014, 353, 2, 182, , , , , , , , , ,